Stay updated on CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial page.

Latest updates to the CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial page
- Check5 days agoChange DetectedThe page revision stamp updated from v3.5.4 to v3.5.5, indicating a small backend update to the study record metadata. There is no indication that substantive study details were modified.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedAdds a new CABOSUN trial publication reference to Publications, including author names. The previous Cabozantinib vs Sunitinib citation and its erratum details are removed.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page footer “Revision” number was updated from v3.5.2 to v3.5.3, indicating a platform/version update without changing the underlying study information.SummaryDifference0.1%

- Check55 days agoChange DetectedAdded: Cabozantinib Versus Sunitinib... CABOSUN Trial publication (Choueiri et al., J Clin Oncol 2017) with erratum and subsequent updates (v3.5.2). Deleted: the earlier CABOSUN JCO 2017 entry (v3.5.0).SummaryDifference0.1%

- Check85 days agoChange DetectedRevision: v3.5.0 added; Revision: v3.4.3 removed.SummaryDifference0.1%

- Check92 days agoChange DetectedFooter revision label updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

Stay in the know with updates to CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial page.